Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

PHASE3TerminatedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCVNASH - Nonalcoholic SteatohepatitisHIV InfectionThrombocytopeniaHepatitis C VirusHBVHuman Immunodeficiency VirusLiver DiseasesHepatitis B Virus
Interventions
DRUG

Eltrombopag

75 mg, once daily, oral

DRUG

Placebo

placebo, once daily, oral

Trial Locations (107)

100

GSK Investigational Site, Taipei

112

GSK Investigational Site, Taipei

640

GSK Investigational Site, Douliu

807

GSK Investigational Site, Kaohsiung City

1070

GSK Investigational Site, Brussels

1264

GSK Investigational Site, Buenos Aires

2650

GSK Investigational Site, Edegem

9000

GSK Investigational Site, Ghent

10021

GSK Investigational Site, New York

10126

GSK Investigational Site, Turin

10595

GSK Investigational Site, Valhalla

13385

GSK Investigational Site, Marseille

16132

GSK Investigational Site, Genoa

19140

GSK Investigational Site, Philadelphia

20122

GSK Investigational Site, Milan

20132

GSK Investigational Site, Milan

20162

GSK Investigational Site, Milan

20307

GSK Investigational Site, Washington D.C.

21202

GSK Investigational Site, Baltimore

22046

GSK Investigational Site, Falls Church

22908

GSK Investigational Site, Charlottesville

23249

GSK Investigational Site, Richmond

23298

GSK Investigational Site, Richmond

27715

GSK Investigational Site, Durham

28007

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28203

GSK Investigational Site, Charlotte

29010

GSK Investigational Site, Málaga

29425

GSK Investigational Site, Charleston

32224

GSK Investigational Site, Jacksonville

33006

GSK Investigational Site, Oviedo

33125

GSK Investigational Site, Miami

33136

GSK Investigational Site, Miami

34295

GSK Investigational Site, Montpellier

35128

GSK Investigational Site, Padua

37232

GSK Investigational Site, Nashville

40138

GSK Investigational Site, Bologna

41013

GSK Investigational Site, Seville

46009

GSK Investigational Site, Valencia

46014

GSK Investigational Site, Valencia

46202

GSK Investigational Site, Indianapolis

47012

GSK Investigational Site, Valladolid

48109

GSK Investigational Site, Ann Arbor

48202

GSK Investigational Site, Detroit

48903

GSK Investigational Site, Barakaldo

54000

GSK Investigational Site, Lahore

54600

GSK Investigational Site, Lahore

60637

GSK Investigational Site, Chicago

63058

GSK Investigational Site, Clermont Ferrand Cédex 1

69288

GSK Investigational Site, Lyon

69437

GSK Investigational Site, Lyon

70112

GSK Investigational Site, New Orleans

70124

GSK Investigational Site, Bari

71013

GSK Investigational Site, San Giovanni Rotondo (FG)

75014

GSK Investigational Site, Paris

75235

GSK Investigational Site, Dallas

75571

GSK Investigational Site, Paris

75651

GSK Investigational Site, Paris

80123

GSK Investigational Site, Napoli

80262

GSK Investigational Site, Denver

83100

GSK Investigational Site, Avellino

85259

GSK Investigational Site, Scottsdale

90048

GSK Investigational Site, Los Angeles

90127

GSK Investigational Site, Palermo

94115

GSK Investigational Site, San Francisco

94804

GSK Investigational Site, Villejuif

97239

GSK Investigational Site, Portland

194044

GSK Investigational Site, Saint Petersburg

214006

GSK Investigational Site, Smolensk

302004

GSK Investigational Site, Jaipur

400020

GSK Investigational Site, Mumbai

443011

GSK Investigational Site, Samara

620102

GSK Investigational Site, Yekaterinburg

35294-0005

GSK Investigational Site, Birmingham

72205-7199

GSK Investigational Site, Little Rock

92103-8707

GSK Investigational Site, San Diego

02215

GSK Investigational Site, Boston

01805

GSK Investigational Site, Burlington

17033-0850

GSK Investigational Site, Hershey

Unknown

GSK Investigational Site, Capital Fefderal

GSK Investigational Site, Taoyuan District

C1181ACI

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

B1629AHJ

GSK Investigational Site, Derqui, Pilar

S2002KDR

GSK Investigational Site, Rosario

T2N 4Z6

GSK Investigational Site, Calgary

K1H 8L6

GSK Investigational Site, Ottawa

M6H 3M1

GSK Investigational Site, Toronto

H2X 3J4

GSK Investigational Site, Montreal

06202

GSK Investigational Site, Nice

400 016

GSK Investigational Site, Mumbai

00133

GSK Investigational Site, Rome

00168

GSK Investigational Site, Rome

41-500

GSK Investigational Site, Chorzów

59-301

GSK Investigational Site, Lubin

76-200

GSK Investigational Site, Słupsk

01-201

GSK Investigational Site, Warsaw

50-367

GSK Investigational Site, Wroclaw

614-735

GSK Investigational Site, Busan

400-711

GSK Investigational Site, Incheon

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

08003

GSK Investigational Site, Barcelona

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY